Response to Comments: MolDX: Xpresys Lung

This record documents the Response to Comments for the MolDX: Xpresys Lung LCD (DL37062), including the comment period (02/08/2017–04/10/2017), notice period (08/14/2017–09/28/2017), and the LCD final effective date (09/29/2017). The document does not itself state clinical coverage criteria, limitations, documentation requirements for claims, or frequency limits.

"This document is a response to comments for MolDX: Xpresys Lung Local Coverage Determination (LCD) DL37062; it records the comment period (02/08/2017–04/10/2017), notice period (08/14/2017–09/28/20..."

Sign up to see full coverage criteria, indications, and limitations.